The Moving Average Convergence Divergence (MACD) for ARDT turned positive on October 07, 2026. Looking at past instances where ARDT's MACD turned positive, the stock continued to rise in 15 of 18 cases over the following month. The odds of a continued upward trend are 83%.
The Momentum Indicator moved above the 0 level on October 07, 2026. You may want to consider a long position or call options on ARDT as a result. In 36 of 49 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.
ARDT moved above its 50-day moving average on October 07, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for ARDT crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 3 of 5 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 60%.
Following a +4.36% 3-day Advance, the price is estimated to grow further. Considering data from situations where ARDT advanced for three days, in 85 of 118 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARDT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
ARDT broke above its upper Bollinger Band on October 08, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ARDT entered a downward trend on October 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 3 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. ARDT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 71 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.259) is normal, around the industry mean (204.132). P/E Ratio (22.135) is within average values for comparable stocks, (18.957). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.100) among similar stocks. P/S Ratio (0.238) is also within normal values, averaging (2.688).
The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARDT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.
THC saw its Momentum Indicator move above the 0 level on October 07, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 77 similar instances where the indicator turned positive. In 67 of the 77 cases, the stock moved higher in the following days. The odds of a move higher are at 87%.
The Moving Average Convergence Divergence (MACD) for THC just turned positive on October 09, 2026. Looking at past instances where THC's MACD turned positive, the stock continued to rise in 36 of 44 cases over the following month. The odds of a continued upward trend are 82%.
THC moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for THC crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.
Following a +3.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where THC advanced for three days, in 266 of 325 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The 10-day RSI Indicator for THC moved out of overbought territory on October 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 56 similar instances where the indicator moved out of overbought territory. In 36 of the 56 cases, the stock moved lower in the following days. This puts the odds of a move lower at 64%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 36 of 61 cases where THC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 59%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where THC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.
THC broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for THC entered a downward trend on October 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is 15 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock better than average.
The Tickeron SMR rating for this company is 20 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. THC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 64 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.652) is normal, around the industry mean (204.132). P/E Ratio (10.327) is within average values for comparable stocks, (18.957). Projected Growth (PEG Ratio) (1.789) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.100) among similar stocks. P/S Ratio (1.022) is also within normal values, averaging (2.688).
THC | ||
|---|---|---|
OUTLOOK RATING 1..100 | 25 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 74 Overvalued | |
PROFIT vs RISK RATING 1..100 | 15 | |
SMR RATING 1..100 | 20 | |
PRICE GROWTH RATING 1..100 | 37 | |
P/E GROWTH RATING 1..100 | 64 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| ARDT | THC | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | 1 day ago 64% |
| Stochastic ODDS (%) | 1 day ago 84% | 1 day ago 59% |
| Momentum ODDS (%) | 1 day ago 73% | 1 day ago 87% |
| MACD ODDS (%) | 1 day ago 83% | 1 day ago 82% |
| TrendWeek ODDS (%) | 1 day ago 72% | 1 day ago 73% |
| TrendMonth ODDS (%) | 1 day ago 68% | 1 day ago 78% |
| Advances ODDS (%) | 8 days ago 72% | 8 days ago 82% |
| Declines ODDS (%) | 4 days ago 74% | 4 days ago 66% |
| BollingerBands ODDS (%) | 1 day ago 75% | 1 day ago 59% |
| Aroon ODDS (%) | 1 day ago 71% | 1 day ago 69% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ARDT’s FA Score shows that 1 FA rating(s) are green while THC’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ARDT’s TA Score shows that 5 TA indicator(s) are bullish while THC’s TA Score has 5 bullish TA indicator(s).
ARDT (@Hospital/Nursing Management) experienced а +0.92% price change this week, while THC (@Hospital/Nursing Management) price change was -1.64% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +1.15%. For the same industry, the average monthly price growth was -3.02%, and the average quarterly price growth was +22.32%.
ARDT is expected to report earnings on Nov 04, 2026.
THC is expected to report earnings on Oct 29, 2026.
Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
A.I.dvisor tells us that ARDT and HCA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ARDT and HCA's prices will move in lockstep.
| Ticker / NAME | Correlation To ARDT | 1D Price Change % | ||
|---|---|---|---|---|
| ARDT | 100% | +2.49% | ||
| HCA - ARDT | 30% Poorly correlated | +1.72% | ||
| ADUS - ARDT | 30% Poorly correlated | +4.00% | ||
| PNTG - ARDT | 28% Poorly correlated | +2.90% | ||
| THC - ARDT | 27% Poorly correlated | +0.56% | ||
| CON - ARDT | 27% Poorly correlated | +2.25% | ||
More | ||||